88 related articles for article (PubMed ID: 8496820)
21. Effects of (-)-tertatolol, (-)-penbutolol and (+/-)-pindolol in combination with paroxetine on presynaptic 5-HT function: an in vivo microdialysis and electrophysiological study.
Gartside SE; Clifford EM; Cowen PJ; Sharp T
Br J Pharmacol; 1999 May; 127(1):145-52. PubMed ID: 10369467
[TBL] [Abstract][Full Text] [Related]
22. (-)-pindolol and (+/-)-tertatolol affect rat hippocampal 5-HT levels through mechanisms involving not only 5-HT1A, but also 5-HT1B receptors.
Assie MB; Koek W
Neuropharmacology; 1996 Feb; 35(2):213-22. PubMed ID: 8734491
[TBL] [Abstract][Full Text] [Related]
23. Serotonin (1A) receptor ligands act on norepinephrine neuron firing through excitatory amino acid and GABA(A) receptors: a microiontophoretic study in the rat locus coeruleus.
Szabo ST; Blier P
Synapse; 2001 Dec; 42(4):203-12. PubMed ID: 11746719
[TBL] [Abstract][Full Text] [Related]
24. Modulation of the firing activity of noradrenergic neurones in the rat locus coeruleus by the 5-hydroxtryptamine system.
Haddjeri N; de Montigny C; Blier P
Br J Pharmacol; 1997 Mar; 120(5):865-75. PubMed ID: 9138693
[TBL] [Abstract][Full Text] [Related]
25. Identification and classification of 5-HT1 receptor subtypes.
Göthert M; Schlicker E
J Cardiovasc Pharmacol; 1990; 15 Suppl 7():S1-7. PubMed ID: 1702482
[TBL] [Abstract][Full Text] [Related]
26. MP-3022, a new putative antagonist at pre- and postsynaptic 5-HT1A receptors.
Przegaliński E; Filip M; Bijak M; Wedzony K; Budziszewska B; Tokarski K; Maćkowiak M; Fijał K
Pol J Pharmacol; 1996; 48(1):13-22. PubMed ID: 9112623
[TBL] [Abstract][Full Text] [Related]
27. Roles of 5-hydroxytryptamine (5-HT) receptor subtypes in the inhibitory effects of 5-HT on C-fiber responses of spinal wide dynamic range neurons in rats.
Liu FY; Xing GG; Qu XX; Xu IS; Han JS; Wan Y
J Pharmacol Exp Ther; 2007 Jun; 321(3):1046-53. PubMed ID: 17329553
[TBL] [Abstract][Full Text] [Related]
28. Direct activation by dopamine of recombinant human 5-HT1A receptors: comparison with human 5-HT2C and 5-HT3 receptors.
Oz M; Zhang L; Rotondo A; Sun H; Morales M
Synapse; 2003 Dec; 50(4):303-13. PubMed ID: 14556235
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological characterization of serotonin-O-carboxymethyl-glycyl-tyrosinamide, a new selective indolic ligand for 5-hydroxytryptamine (5-HT)1B and 5-HT1D binding sites.
Boulenguez P; Chauveau J; Segu L; Morel A; Delaage M; Lanoir J
J Pharmacol Exp Ther; 1991 Dec; 259(3):1360-5. PubMed ID: 1762084
[TBL] [Abstract][Full Text] [Related]
30. Serotonin receptor subtypes in spinal antinociception in the rat.
Xu W; Qiu XC; Han JS
J Pharmacol Exp Ther; 1994 Jun; 269(3):1182-9. PubMed ID: 8014862
[TBL] [Abstract][Full Text] [Related]
31. 5-HT1A receptors in the median raphe nucleus and dorsal hippocampus may mediate anxiolytic and anxiogenic behaviours respectively.
Andrews N; Hogg S; Gonzalez LE; File SE
Eur J Pharmacol; 1994 Nov; 264(3):259-64. PubMed ID: 7698163
[TBL] [Abstract][Full Text] [Related]
32. Vasodilator effect of tertatolol in isolated perfused rat kidneys: involvement of endothelial 5-HT1A receptors.
Verbeuren TJ
Cardiology; 1993; 83 Suppl 1():5-9. PubMed ID: 7903215
[TBL] [Abstract][Full Text] [Related]
33. WAY 100,135 and (-)-tertatolol act as antagonists at both 5-HT1A autoreceptors and postsynaptic 5-HT1A receptors in vivo.
Lejeune F; Rivet JM; Gobert A; Canton H; Millan MJ
Eur J Pharmacol; 1993 Aug; 240(2-3):307-10. PubMed ID: 8243546
[TBL] [Abstract][Full Text] [Related]
34. Electrophysiological assessment of putative antagonists of 5-hydroxytryptamine receptors: a single-cell study in the rat dorsal raphe nucleus.
Blier P; Steinberg S; Chaput Y; de Montigny C
Can J Physiol Pharmacol; 1989 Feb; 67(2):98-105. PubMed ID: 2523754
[TBL] [Abstract][Full Text] [Related]
35. Reduction of in vivo striatal 5-hydroxytryptamine release by 8-OH-DPAT after inactivation of Gi/G(o) proteins in dorsal raphe nucleus.
Romero L; Celada P; Artigas F
Eur J Pharmacol; 1994 Nov; 265(1-2):103-6. PubMed ID: 7883021
[TBL] [Abstract][Full Text] [Related]
36. Selective serotonin reuptake inhibitors reduce the spontaneous activity of dopaminergic neurons in the ventral tegmental area.
Di Mascio M; Di Giovanni G; Di Matteo V; Prisco S; Esposito E
Brain Res Bull; 1998 Aug; 46(6):547-54. PubMed ID: 9744293
[TBL] [Abstract][Full Text] [Related]
37. Contrasting behavioural effects of 8-OH DPAT in the dorsal raphé nucleus and ventral hippocampus.
Hogg S; Andrews N; File SE
Neuropharmacology; 1994; 33(3-4):343-8. PubMed ID: 7984272
[TBL] [Abstract][Full Text] [Related]
38. Early life adversity programs changes in central 5-HT neuronal function in adulthood.
Gartside SE; Johnson DA; Leitch MM; Troakes C; Ingram CD
Eur J Neurosci; 2003 Jun; 17(11):2401-8. PubMed ID: 12814371
[TBL] [Abstract][Full Text] [Related]
39. The beta adrenoceptor blocker tertatolol causes vasodilatation in the isolated perfused vasoconstricted rat kidney.
Verbeuren TJ; Zonnekeyn LL; Prost JF; Rochat C; Thomas JR; Herman AG
J Pharmacol Exp Ther; 1988 Aug; 246(2):628-34. PubMed ID: 2900328
[TBL] [Abstract][Full Text] [Related]
40. Possible antidepressant dihydroergosine preferentially binds to 5-HT1B receptor sites in the rat hippocampus.
Muck-Seler D; Pericić D
J Neural Transm Gen Sect; 1993; 92(1):1-9. PubMed ID: 8329168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
